Ginkgo Bioworks , which is building the leading platform for cell programming and biosecurity, proudly announces the launch ...

The legal sector's engagement with the staggering potential of artificial intelligence has surprised long-time observers of ...

Gappa's advice for advocacy includes understanding the burden of respiratory disease among children in your area and knowing the factors that affect childhood respiratory health. Use state-of-the-art ...

Adding GSK’s mepolizumab to standard inhaled treatment for COPD reduces the frequency of exacerbations in patients with type ...

GSK has reported positive results from its phase II trial for an mRNA seasonal influenza vaccine candidate, showing strong immune responses again ...

GSK’s depemokimab, a new ultra-long-acting biologic, showed a 54% reduction in severe asthma exacerbations in the SWIFT-1 and ...

Europe can become more competitive when it harnesses the innovative potential of pharmaceutical companies. The Polish ...

Global healthcare company GlaxoSmithKline Pharmaceuticals Ltd on Tuesday (September 3) said it has received an income tax refund of ₹222.23 crore for the assessment year 2022-23, following an order ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

No matter how powerful generative AI becomes, writer Ted Chiang says it will never create true art. Chiang is one of the most admired science-fiction authors writing today, best known for the ...

Also Read | Despite a 134% jump in last 1 year, Elara has a sell call on this defense stock HUL finalized its merger with GlaxoSmithKline Consumer Healthcare Limited (GSKCH) in 2020, after ...

The tax demand arises from the company's non-deduction of Tax Deducted at Source (TDS) related to a remittance of Rs 3,045 crore made for the acquisition of India Health Food Drink's (HFD) ...